News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

OncoArendi featured in Labiotech.eu

19 July 2017

OncoArendi Therapeutics announced today that it has filed a Clinical Trial Application (CTA)

7 July 2017

OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers

21 June 2017

OncoArendi raises 4.5 mln USD (18 million PLN) in an extension of Series A financing round

8 March 2017

OncoArendi receives the President’s Economic Award as the best Polish R&D Company in 2016

17 November 2016

OncoArendi Therapeutics has entered into a global license agreement with Yale University

10 February 2015

Events & Presentations

ESMO – 8-12 September 2017 Madrid

1 September 2017

ERS – 9-13 September 2017 Milan

1 September 2017

BIO USA – San Diego 19-22 June 2017

1 June 2017

ATS – Washington 19-24 May 2017

1 May 2017
This site is registered on wpml.org as a development site.